Recursion Pharmaceuticals Inc Clas (RXRX)

Net Change in Cash

-$108.36M

Quarterly · Period ending: · USD

RXRX logo

RXRX Net Change in Cash

Latest reported-$108.36M
RXRX Quarterly Net Change in Cash (-$12.50M → -$108.36M)
High-resolution chart · PNG

RXRX net change in cash history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Recursion Pharmaceuticals Inc Clas Net Change in Cash — Quarterly (USD)
Period endingNet Change in Cash (USD)
-108,360,000
-88,741,000
86,776,000
133,300,000
24,688,000
-93,867,000
167,193,000
-46,922,000
176,603,000
-95,275,000
4,218,000
-19,617,000
-65,552,000
-76,736,000
94,456,000
960,000
-53,636,000
222,744,000
-118,286,000
-238,016,000
423,840,000
-48,037,000
14,017,000
206,839,000
-16,356,000
-12,504,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.